LORVIQUE Trademark

Trademark Overview


On Friday, November 13, 2015, a trademark application was filed for LORVIQUE with the United States Patent and Trademark Office. The USPTO has given the LORVIQUE trademark a serial number of 86819253. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Monday, April 25, 2016. This trademark is owned by Pfizer Inc.. The LORVIQUE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
lorvique

General Information


Serial Number86819253
Word MarkLORVIQUE
Filing DateFriday, November 13, 2015
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateMonday, April 25, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 23, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateMonday, April 25, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, April 25, 2016ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Monday, April 25, 2016ABANDONMENT - AFTER PUBLICATION
Thursday, April 21, 2016TEAS EXPRESS ABANDONMENT RECEIVED
Monday, March 21, 2016EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 23, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 23, 2016PUBLISHED FOR OPPOSITION
Wednesday, February 3, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 8, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 8, 2016ASSIGNED TO EXAMINER
Wednesday, November 18, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 17, 2015NEW APPLICATION ENTERED IN TRAM